These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 11973118)

  • 1. Risperidone in the treatment of psychoses in the elderly: a case report series.
    Bullock R; Libretto S
    Eur Psychiatry; 2002 Apr; 17(2):96-103. PubMed ID: 11973118
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacology and clinical experience with risperidone.
    Love RC; Nelson MW
    Expert Opin Pharmacother; 2000 Dec; 1(7):1441-53. PubMed ID: 11249477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First generation antipsychotics switch with Risperidone in the treatment of chronic schizophrenic patients.
    Popović I; Ravanić D; Popović V; Vladejić S; Stanojević A; Stojanović M
    Psychiatr Danub; 2011 Dec; 23(4):384-8. PubMed ID: 22075740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Atypical antipsychotics for psychosis in adolescents.
    Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
    Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD009582. PubMed ID: 24129841
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A comparison of the relative safety, efficacy, and tolerability of quetiapine and risperidone in outpatients with schizophrenia and other psychotic disorders: the quetiapine experience with safety and tolerability (QUEST) study.
    Mullen J; Jibson MD; Sweitzer D
    Clin Ther; 2001 Nov; 23(11):1839-54. PubMed ID: 11768836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A trial of low doses of risperidone in the treatment of patients with first-episode schizophrenia, schizophreniform disorder, or schizoaffective disorder.
    Huq ZU;
    J Clin Psychopharmacol; 2004 Apr; 24(2):220-4. PubMed ID: 15206670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral risperidone plus oral lorazepam versus standard care with intramuscular conventional neuroleptics in the initial phase of treating individuals with acute psychosis.
    Lejeune J; Larmo I; Chrzanowski W; Witte R; Karavatos A; Schreiner A; Lex A; Medori R
    Int Clin Psychopharmacol; 2004 Sep; 19(5):259-69. PubMed ID: 15289699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risperidone in the treatment of elderly patients with psychotic disorders.
    Madhusoodanan S; Brecher M; Brenner R; Kasckow J; Kunik M; Negrón AE; Pomara N
    Am J Geriatr Psychiatry; 1999; 7(2):132-8. PubMed ID: 10322240
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of long-acting risperidone in elderly patients with schizophrenia and schizoaffective disorder.
    Lasser RA; Bossie CA; Zhu Y; Gharabawi G; Eerdekens M; Davidson M
    Int J Geriatr Psychiatry; 2004 Sep; 19(9):898-905. PubMed ID: 15352149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A long-term, multicenter, open-label study of risperidone in elderly patients with psychosis. On behalf of the Risperidone Working Group.
    Davidson M; Harvey PD; Vervarcke J; Gagiano CA; De Hooge JD; Bray G; Dose M; Barak Y; Haushofer M
    Int J Geriatr Psychiatry; 2000 Jun; 15(6):506-14. PubMed ID: 10861916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
    Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
    Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and efficacy of long-acting risperidone in schizophrenia: a 12-week, multicenter, open-label study in stable patients switched from typical and atypical oral antipsychotics.
    Lindenmayer JP; Eerdekens E; Berry SA; Eerdekens M
    J Clin Psychiatry; 2004 Aug; 65(8):1084-9. PubMed ID: 15323593
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of direct transition to risperidone long-acting injectable in patients treated with various antipsychotic therapies.
    Möller HJ; Llorca PM; Sacchetti E; Martin SD; Medori R; Parellada E;
    Int Clin Psychopharmacol; 2005 May; 20(3):121-30. PubMed ID: 15812261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse events related to olanzapine.
    Conley RR; Meltzer HY
    J Clin Psychiatry; 2000; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Would a switch from typical antipsychotics to risperidone be beneficial for elderly schizophrenic patients? A naturalistic, long-term, retrospective, comparative study.
    Barak Y; Shamir E; Weizman R
    J Clin Psychopharmacol; 2002 Apr; 22(2):115-20. PubMed ID: 11910255
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sustained improvement of clinical outcome with risperidone long-acting injectable in psychotic patients previously treated with olanzapine.
    Gastpar M; Masiak M; Latif MA; Frazzingaro S; Medori R; Lombertie ER
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):32-8. PubMed ID: 16144784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of risperidone versus olanzapine in patients with schizophrenia previously on chronic conventional antipsychotic therapy: a switch study.
    Wang X; Savage R; Borisov A; Rosenberg J; Woolwine B; Tucker M; May R; Feldman J; Nemeroff CB; Miller AH
    J Psychiatr Res; 2006 Oct; 40(7):669-76. PubMed ID: 16762371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients in the early phases of schizophrenia and schizoaffective disorders effectively treated with risperidone long-acting injectable.
    Parellada E; Andrezina R; Milanova V; Glue P; Masiak M; Turner MS; Medori R; Gaebel W
    J Psychopharmacol; 2005 Sep; 19(5 Suppl):5-14. PubMed ID: 16144781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N; Foster RH; Olney R; Plosker GL
    Drugs; 2001; 61(1):111-61. PubMed ID: 11217867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Long-acting injectable risperidone: naturalistic study in three hospitals in Aquitaine].
    Raignoux C; Dusouchet T; Bret P; Queuille E; Biscay ML; Caron J; Bret MC
    Encephale; 2007 Dec; 33(6):973-81. PubMed ID: 18789790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.